Platelet-Rich Plasma (PRB) combined with Medial Calcaneal Nerve Block in patients with planter fasciitis

Effect Of Combined Medial Calcaneal nerve Block and platelet rich plasma for planter fascitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308825168287

Enrollment

Registered

2023-08-18

Start date

2022-06-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Anaesthesia

Interventions

PRP with MCNB

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Cases with six-months minimum of conservative therapies, such as icepacks, stretching of the Achilles tendon and NSAID medication, which provided inadequate improvement of pain and function

Exclusion criteria

Exclusion criteria: • Other associated pathologies (alterations in ipsilateral ankle and knee, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, Reiter’s syndrome). • Neurological abnormalities. • Skin infections. • History of infection at the application site (within the previous three months). • Coagulopathies such as Hemophilia, Von Willebrand disease, clotting factor deficiencies, hypercoagulable states and deep venous thrombsis .

Design outcomes

Primary

Measure	Time frame
Primary outcome is Measurement of pain intensity using visual analog scale (VAS).	—

Secondary

Measure	Time frame
Secondary outcomes are Measurement of Functional Limitation using Foot Function Index (FFI) and Patient satisfaction using (modified criteria of the Roles and Maudsley score)	—

Countries

Egypt

Contacts

Public ContactGhada El Rahmawy

Professor

aslany.salama@gmail.com+201550434587

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026